139 related articles for article (PubMed ID: 26813215)
1. Safety of Propranolol Therapy for Severe Infantile Hemangioma.
Prey S; Voisard JJ; Delarue A; Lebbe G; Taïeb A; Leaute-Labreze C; Ezzedine K
JAMA; 2016 Jan; 315(4):413-5. PubMed ID: 26813215
[No Abstract] [Full Text] [Related]
2. Oral propranolol (Hemangeol) for infantile hemangioma.
Med Lett Drugs Ther; 2014 Jul; 56(1447):61-2. PubMed ID: 25046418
[No Abstract] [Full Text] [Related]
3. When to stop propranolol for infantile hemangioma.
Chang L; Gu Y; Yu Z; Ying H; Qiu Y; Ma G; Chen H; Jin Y; Lin X
Sci Rep; 2017 Feb; 7():43292. PubMed ID: 28225076
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of external propranolol gel for treatment of superficial infantile hemangioma].
Qi M; Chen X; Xie HF; Ding JS; Jian D; Zhang JL
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Aug; 16(8):860-2. PubMed ID: 25140783
[No Abstract] [Full Text] [Related]
5. [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].
Zhao ZF; Lü RR; Zhang J; Huo R; Xu GQ; Fu HB; Guo X; Wui JC; Lin LL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):174-7. PubMed ID: 21837994
[TBL] [Abstract][Full Text] [Related]
6. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol for infantile haemangioma may be associated with transient gross motor delay.
Mahon C; Heron G; Perkins D; Drage A; Wargon O
Br J Dermatol; 2018 Jun; 178(6):1443-1444. PubMed ID: 29330846
[No Abstract] [Full Text] [Related]
8. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
9. In brief: oral propranolol infantile hemangiomas.
Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
[No Abstract] [Full Text] [Related]
10. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
11. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
Wedgeworth E; Glover M; Irvine AD; Neri I; Baselga E; Clayton TH; Beattie PE; Bjerre JV; Burrows NP; Foelster-Holst R; Hedelund L; Hernandez-Martin A; Audrain H; Bhate K; Brown SJ; Baryschpolec S; Darne S; Durack A; Dvorakova V; Gach J; Goldstraw N; Goodyear H; Grabczynska S; Greenblatt D; Halpern J; Hearn RM; Hoey S; Hughes B; Jayaraj R; Johansson EK; Lam M; Leech S; O'Regan GM; Morrison D; Porter W; Ramesh R; Schill T; Shaw L; Taylor AE; Taylor R; Thomson J; Tiffin P; Tsakok M; Janmohamed SR; Laguda B; McPherson T; Oranje AP; Patrizi A; Ravenscroft JC; Shahidullah H; Solman L; Svensson A; Wahlgren CF; Hoeger PH; Flohr C
Br J Dermatol; 2016 Mar; 174(3):594-601. PubMed ID: 26473312
[TBL] [Abstract][Full Text] [Related]
12. [Propranolol in the therapy of infantile hemangioma--fascinating, but not with risk].
Fölster-Holst R
J Dtsch Dermatol Ges; 2010 Mar; 8(3):149-50. PubMed ID: 20406338
[No Abstract] [Full Text] [Related]
13. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
14. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.
Ahogo CK; Ezzedine K; Prey S; Colona V; Diallo A; Boralevi F; Taïeb A; Léauté-Labrèze C
Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995
[TBL] [Abstract][Full Text] [Related]
16. Dental caries as a side effect of infantile hemangioma treatment with propranolol solution.
Girón-Vallejo O; López-Gutiérrez JC; Fernández-Pineda I; Méndez NA; Ruiz Jiménez JI
Pediatr Dermatol; 2010; 27(6):672-3. PubMed ID: 21510011
[TBL] [Abstract][Full Text] [Related]
17. Safety of Oral Propranolol for Infantile Hemangioma.
Droitcourt C; Kerbrat S; Rault C; Botrel MA; Happe A; Garlantezec R; Guillot B; Schleich JM; Oger E; Dupuy A
Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29844139
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
19. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
Luo Y; Zeng Y; Zhou B; Tang J
Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
